Annette Marcantonio
Corporate Officer/Principal bij JASPER THERAPEUTICS, INC.
Actieve functies van Annette Marcantonio
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
JASPER THERAPEUTICS, INC. | Corporate Officer/Principal | 02-08-2023 | - |
Loopbaan van Annette Marcantonio
Eerdere bekende functies van Annette Marcantonio
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Neurogastrx, Inc.
Neurogastrx, Inc. BiotechnologyHealth Technology Neurogastrx, Inc. operates as a venture-stage biopharmaceutical company. The firm develops biopharmaceutical products for the treatment of gastrointestinal disorders. It offers NG101, a product for the treatment of gastroparesis. The company was founded by Cyril De Colle and Pankaj Jay Pasricha and is headquartered in Campbell, CA. | Corporate Officer/Principal | 01-09-2021 | 01-12-2022 |
AIMMUNE THERAPEUTICS, INC. | Corporate Officer/Principal | 01-09-2016 | 01-10-2020 |
Opleiding van Annette Marcantonio
Loyola Marymount University | Undergraduate Degree |
University of Phoenix | Masters Business Admin |
Statistieken
Internationaal
Verenigde Staten | 6 |
Operationeel
Corporate Officer/Principal | 3 |
Undergraduate Degree | 1 |
Masters Business Admin | 1 |
Sectoraal
Health Technology | 3 |
Consumer Services | 3 |
Finance | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
JASPER THERAPEUTICS, INC. | Finance |
Bedrijven in privébezit | 2 |
---|---|
Aimmune Therapeutics, Inc.
Aimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aimmune Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of desensitization treatments for peanut and other food allergies. Its portfolio includes the characterized oral desensitization immunotherapy system. The firm product include Palforzia, which is an oral immunotherapy indicated for the mitigation of allergic reactions, including anaphylaxis that may occur with accidental exposure to peanut. The company was founded on June 24, 2011 and is headquartered in Brisbane, CA. | Health Technology |
Neurogastrx, Inc.
Neurogastrx, Inc. BiotechnologyHealth Technology Neurogastrx, Inc. operates as a venture-stage biopharmaceutical company. The firm develops biopharmaceutical products for the treatment of gastrointestinal disorders. It offers NG101, a product for the treatment of gastroparesis. The company was founded by Cyril De Colle and Pankaj Jay Pasricha and is headquartered in Campbell, CA. | Health Technology |
- Beurs
- Insiders
- Annette Marcantonio
- Ervaring